BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Science in Vancouver - ECPv6.15.18//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://scienceinvancouver.com
X-WR-CALDESC:Events for Science in Vancouver
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Vancouver
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20190310T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20191103T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20200308T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20201101T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20210314T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20211107T090000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200623T080000
DTEND;TZID=America/Vancouver:20200623T170000
DTSTAMP:20260405T050005
CREATED:20200623T140116Z
LAST-MODIFIED:20200623T140116Z
UID:11792-1592899200-1592931600@scienceinvancouver.com
SUMMARY:SBME Virtual Seminar: Leah Edelstein-Keshet & Samuel Shin
DESCRIPTION:
URL:https://scienceinvancouver.com/event/sbme-virtual-seminar-leah-edelstein-keshet-samuel-shin/
LOCATION:British Columbia
ATTACH;FMTTYPE=image/jpeg:https://scienceinvancouver.com/wp-content/uploads/sites/1/2020/06/SBME-seminar-June-25.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200623T080000
DTEND;TZID=America/Vancouver:20200623T170000
DTSTAMP:20260405T050005
CREATED:20200623T140116Z
LAST-MODIFIED:20200623T140116Z
UID:26198-1592899200-1592931600@scienceinvancouver.com
SUMMARY:SBME Virtual Seminar: Leah Edelstein-Keshet & Samuel Shin
DESCRIPTION:
URL:https://scienceinvancouver.com/event/sbme-virtual-seminar-leah-edelstein-keshet-samuel-shin-2/
LOCATION:British Columbia
ATTACH;FMTTYPE=image/jpeg:https://scienceinvancouver.com/wp-content/uploads/sites/1/2020/06/SBME-seminar-June-25.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200623T080000
DTEND;TZID=America/Vancouver:20200623T170000
DTSTAMP:20260405T050005
CREATED:20200623T140116Z
LAST-MODIFIED:20200623T140116Z
UID:27813-1592899200-1592931600@scienceinvancouver.com
SUMMARY:SBME Virtual Seminar: Leah Edelstein-Keshet & Samuel Shin
DESCRIPTION:
URL:https://scienceinvancouver.com/event/sbme-virtual-seminar-leah-edelstein-keshet-samuel-shin-3/
LOCATION:British Columbia
ATTACH;FMTTYPE=image/jpeg:https://scienceinvancouver.com/wp-content/uploads/sites/1/2020/06/SBME-seminar-June-25.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200623T080000
DTEND;TZID=America/Vancouver:20200623T170000
DTSTAMP:20260405T050005
CREATED:20200623T140116Z
LAST-MODIFIED:20200623T140116Z
UID:30896-1592899200-1592931600@scienceinvancouver.com
SUMMARY:SBME Virtual Seminar: Leah Edelstein-Keshet & Samuel Shin
DESCRIPTION:
URL:https://scienceinvancouver.com/event/sbme-virtual-seminar-leah-edelstein-keshet-samuel-shin-4/
LOCATION:British Columbia
ATTACH;FMTTYPE=image/jpeg:https://scienceinvancouver.com/wp-content/uploads/sites/1/2020/06/SBME-seminar-June-25.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200623T080000
DTEND;TZID=America/Vancouver:20200623T170000
DTSTAMP:20260405T050005
CREATED:20200623T140116Z
LAST-MODIFIED:20200623T140116Z
UID:32356-1592899200-1592931600@scienceinvancouver.com
SUMMARY:SBME Virtual Seminar: Leah Edelstein-Keshet & Samuel Shin
DESCRIPTION:
URL:https://scienceinvancouver.com/event/sbme-virtual-seminar-leah-edelstein-keshet-samuel-shin-5/
LOCATION:British Columbia
ATTACH;FMTTYPE=image/jpeg:https://scienceinvancouver.com/wp-content/uploads/sites/1/2020/06/SBME-seminar-June-25.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200624T100000
DTEND;TZID=America/Vancouver:20200624T110000
DTSTAMP:20260405T050005
CREATED:20200609T163508Z
LAST-MODIFIED:20200609T163508Z
UID:11664-1592992800-1592996400@scienceinvancouver.com
SUMMARY:STAT Webinar: Targeted Cancer Drugs: What’s on the Market? What’s in the Pipeline?
DESCRIPTION:While immunotherapies get most of the headlines\, targeted cancer treatments have revolutionized oncology in recent years\, changing the lives of some patients by homing in on genetically defined tumors. Join STAT’s Damian Garde for this webinar\, where he’ll take a look at some of the most important recently approved targeted therapies  and examine the pipeline of medicines yet to come. That means looking at the underlying science\, the clinical data\, and the often surprising costs associated with these drugs.
URL:https://scienceinvancouver.com/event/stat-webinar-targeted-cancer-drugs-whats-on-the-market-whats-in-the-pipeline/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200624T100000
DTEND;TZID=America/Vancouver:20200624T110000
DTSTAMP:20260405T050005
CREATED:20200609T163508Z
LAST-MODIFIED:20200609T163508Z
UID:26188-1592992800-1592996400@scienceinvancouver.com
SUMMARY:STAT Webinar: Targeted Cancer Drugs: What’s on the Market? What’s in the Pipeline?
DESCRIPTION:While immunotherapies get most of the headlines\, targeted cancer treatments have revolutionized oncology in recent years\, changing the lives of some patients by homing in on genetically defined tumors. Join STAT’s Damian Garde for this webinar\, where he’ll take a look at some of the most important recently approved targeted therapies  and examine the pipeline of medicines yet to come. That means looking at the underlying science\, the clinical data\, and the often surprising costs associated with these drugs.
URL:https://scienceinvancouver.com/event/stat-webinar-targeted-cancer-drugs-whats-on-the-market-whats-in-the-pipeline-2/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200624T100000
DTEND;TZID=America/Vancouver:20200624T110000
DTSTAMP:20260405T050005
CREATED:20200609T163508Z
LAST-MODIFIED:20200609T163508Z
UID:27803-1592992800-1592996400@scienceinvancouver.com
SUMMARY:STAT Webinar: Targeted Cancer Drugs: What’s on the Market? What’s in the Pipeline?
DESCRIPTION:While immunotherapies get most of the headlines\, targeted cancer treatments have revolutionized oncology in recent years\, changing the lives of some patients by homing in on genetically defined tumors. Join STAT’s Damian Garde for this webinar\, where he’ll take a look at some of the most important recently approved targeted therapies  and examine the pipeline of medicines yet to come. That means looking at the underlying science\, the clinical data\, and the often surprising costs associated with these drugs.
URL:https://scienceinvancouver.com/event/stat-webinar-targeted-cancer-drugs-whats-on-the-market-whats-in-the-pipeline-3/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200624T100000
DTEND;TZID=America/Vancouver:20200624T110000
DTSTAMP:20260405T050005
CREATED:20200609T163508Z
LAST-MODIFIED:20200609T163508Z
UID:30886-1592992800-1592996400@scienceinvancouver.com
SUMMARY:STAT Webinar: Targeted Cancer Drugs: What’s on the Market? What’s in the Pipeline?
DESCRIPTION:While immunotherapies get most of the headlines\, targeted cancer treatments have revolutionized oncology in recent years\, changing the lives of some patients by homing in on genetically defined tumors. Join STAT’s Damian Garde for this webinar\, where he’ll take a look at some of the most important recently approved targeted therapies  and examine the pipeline of medicines yet to come. That means looking at the underlying science\, the clinical data\, and the often surprising costs associated with these drugs.
URL:https://scienceinvancouver.com/event/stat-webinar-targeted-cancer-drugs-whats-on-the-market-whats-in-the-pipeline-4/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200624T100000
DTEND;TZID=America/Vancouver:20200624T110000
DTSTAMP:20260405T050005
CREATED:20200609T163508Z
LAST-MODIFIED:20200609T163508Z
UID:32346-1592992800-1592996400@scienceinvancouver.com
SUMMARY:STAT Webinar: Targeted Cancer Drugs: What’s on the Market? What’s in the Pipeline?
DESCRIPTION:While immunotherapies get most of the headlines\, targeted cancer treatments have revolutionized oncology in recent years\, changing the lives of some patients by homing in on genetically defined tumors. Join STAT’s Damian Garde for this webinar\, where he’ll take a look at some of the most important recently approved targeted therapies  and examine the pipeline of medicines yet to come. That means looking at the underlying science\, the clinical data\, and the often surprising costs associated with these drugs.
URL:https://scienceinvancouver.com/event/stat-webinar-targeted-cancer-drugs-whats-on-the-market-whats-in-the-pipeline-5/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200625T093000
DTEND;TZID=America/Vancouver:20200625T123000
DTSTAMP:20260405T050005
CREATED:20200521T203711Z
LAST-MODIFIED:20200521T203711Z
UID:11411-1593077400-1593088200@scienceinvancouver.com
SUMMARY:Image Guided Therapeutics: from Conception to Commercialization
DESCRIPTION:Join UBC’s Materials and Manufacturing Institute\, the University of Colorado\, Ryerson University\, Sunnybrook Research Institute and the Biomedical Imaging & AI cluster on June 25th for the online webinar “Image Guided Therapeutics: from Conception to Commercialization”. \nThe virtual event will bring together lead academic and research organizations in the field of biomedical imaging to share institutional research highlights and an overview of their current initiatives. The seminar aims to facilitate collaboration and identify new opportunities for partnership. Please join us on June 25th and learn how you can connect with our international and multi-institutional group of directors and researchers.
URL:https://scienceinvancouver.com/event/image-guided-therapeutics-from-conception-to-commercialization/
LOCATION:Online
ATTACH;FMTTYPE=image/jpeg:https://scienceinvancouver.com/wp-content/uploads/sites/1/2020/05/Image-Guided-Therapeutics.jpeg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200625T093000
DTEND;TZID=America/Vancouver:20200625T123000
DTSTAMP:20260405T050005
CREATED:20200521T203711Z
LAST-MODIFIED:20200521T203711Z
UID:26171-1593077400-1593088200@scienceinvancouver.com
SUMMARY:Image Guided Therapeutics: from Conception to Commercialization
DESCRIPTION:Join UBC’s Materials and Manufacturing Institute\, the University of Colorado\, Ryerson University\, Sunnybrook Research Institute and the Biomedical Imaging & AI cluster on June 25th for the online webinar “Image Guided Therapeutics: from Conception to Commercialization”. \nThe virtual event will bring together lead academic and research organizations in the field of biomedical imaging to share institutional research highlights and an overview of their current initiatives. The seminar aims to facilitate collaboration and identify new opportunities for partnership. Please join us on June 25th and learn how you can connect with our international and multi-institutional group of directors and researchers.
URL:https://scienceinvancouver.com/event/image-guided-therapeutics-from-conception-to-commercialization-3/
LOCATION:Online
ATTACH;FMTTYPE=image/jpeg:https://scienceinvancouver.com/wp-content/uploads/sites/1/2020/05/Image-Guided-Therapeutics.jpeg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200625T093000
DTEND;TZID=America/Vancouver:20200625T123000
DTSTAMP:20260405T050005
CREATED:20200521T203711Z
LAST-MODIFIED:20200521T203711Z
UID:27786-1593077400-1593088200@scienceinvancouver.com
SUMMARY:Image Guided Therapeutics: from Conception to Commercialization
DESCRIPTION:Join UBC’s Materials and Manufacturing Institute\, the University of Colorado\, Ryerson University\, Sunnybrook Research Institute and the Biomedical Imaging & AI cluster on June 25th for the online webinar “Image Guided Therapeutics: from Conception to Commercialization”. \nThe virtual event will bring together lead academic and research organizations in the field of biomedical imaging to share institutional research highlights and an overview of their current initiatives. The seminar aims to facilitate collaboration and identify new opportunities for partnership. Please join us on June 25th and learn how you can connect with our international and multi-institutional group of directors and researchers.
URL:https://scienceinvancouver.com/event/image-guided-therapeutics-from-conception-to-commercialization-4/
LOCATION:Online
ATTACH;FMTTYPE=image/jpeg:https://scienceinvancouver.com/wp-content/uploads/sites/1/2020/05/Image-Guided-Therapeutics.jpeg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200625T093000
DTEND;TZID=America/Vancouver:20200625T123000
DTSTAMP:20260405T050005
CREATED:20200521T203711Z
LAST-MODIFIED:20200521T203711Z
UID:30869-1593077400-1593088200@scienceinvancouver.com
SUMMARY:Image Guided Therapeutics: from Conception to Commercialization
DESCRIPTION:Join UBC’s Materials and Manufacturing Institute\, the University of Colorado\, Ryerson University\, Sunnybrook Research Institute and the Biomedical Imaging & AI cluster on June 25th for the online webinar “Image Guided Therapeutics: from Conception to Commercialization”. \nThe virtual event will bring together lead academic and research organizations in the field of biomedical imaging to share institutional research highlights and an overview of their current initiatives. The seminar aims to facilitate collaboration and identify new opportunities for partnership. Please join us on June 25th and learn how you can connect with our international and multi-institutional group of directors and researchers.
URL:https://scienceinvancouver.com/event/image-guided-therapeutics-from-conception-to-commercialization-5/
LOCATION:Online
ATTACH;FMTTYPE=image/jpeg:https://scienceinvancouver.com/wp-content/uploads/sites/1/2020/05/Image-Guided-Therapeutics.jpeg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200625T093000
DTEND;TZID=America/Vancouver:20200625T123000
DTSTAMP:20260405T050005
CREATED:20200521T203711Z
LAST-MODIFIED:20200521T203711Z
UID:32329-1593077400-1593088200@scienceinvancouver.com
SUMMARY:Image Guided Therapeutics: from Conception to Commercialization
DESCRIPTION:Join UBC’s Materials and Manufacturing Institute\, the University of Colorado\, Ryerson University\, Sunnybrook Research Institute and the Biomedical Imaging & AI cluster on June 25th for the online webinar “Image Guided Therapeutics: from Conception to Commercialization”. \nThe virtual event will bring together lead academic and research organizations in the field of biomedical imaging to share institutional research highlights and an overview of their current initiatives. The seminar aims to facilitate collaboration and identify new opportunities for partnership. Please join us on June 25th and learn how you can connect with our international and multi-institutional group of directors and researchers.
URL:https://scienceinvancouver.com/event/image-guided-therapeutics-from-conception-to-commercialization-6/
LOCATION:Online
ATTACH;FMTTYPE=image/jpeg:https://scienceinvancouver.com/wp-content/uploads/sites/1/2020/05/Image-Guided-Therapeutics.jpeg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200625T100000
DTEND;TZID=America/Vancouver:20200625T110000
DTSTAMP:20260405T050005
CREATED:20200608T203949Z
LAST-MODIFIED:20200608T203949Z
UID:11652-1593079200-1593082800@scienceinvancouver.com
SUMMARY:McCarthy Spotlight Speaking Series: Non-Dilutive Funding Programs
DESCRIPTION:LifeSciences BC is pleased to present our Summer McCarthy Spotlight Speaking Event for Thursday\, June 25\, 2020. This webinar will cover the various non-dilutive funding programs that are currently being offered to assist during COVID-19. Speakers will give an overview of their funding programs and how to apply for them. After the presentations\, there will be a question and answer period.  \n  \nConfirmed Speakers:  \n\nGina Arsens\, Chief Financial Officer\, Canada’s Digital Technology Supercluster\nEric Atkinson\, Industrial Technology Advisor\, NRC IRAP\n\n  \nEvent Details  \nDate: June 25\, 2020 \nTime: 10:00 – 11:00 AM \nTickets: Free for everyone  \nThis Spotlight Speaking Series is proudly presented by \n \nOur McCarthy Spotlight Speaking Series is one of our longest-standing event series – and one in which our attendees see the most value. Held twice a year\, these events start with presentations on specific topics by local representatives of LifeSciences BC members. Typically\, the event is attended by a cross-section of approximately 40 of our life sciences community members representing mainly industry\, NPOs\, and Government. \nIn the past\, the series has featured topics focusing on attracting and keeping good talent\, technology and licensing\, M&A and Capital Markets\, to name a few. 
URL:https://scienceinvancouver.com/event/mccarthy-spotlight-speaking-series-non-dilutive-funding-programs/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200625T100000
DTEND;TZID=America/Vancouver:20200625T110000
DTSTAMP:20260405T050005
CREATED:20200608T203949Z
LAST-MODIFIED:20200608T203949Z
UID:26186-1593079200-1593082800@scienceinvancouver.com
SUMMARY:McCarthy Spotlight Speaking Series: Non-Dilutive Funding Programs
DESCRIPTION:LifeSciences BC is pleased to present our Summer McCarthy Spotlight Speaking Event for Thursday\, June 25\, 2020. This webinar will cover the various non-dilutive funding programs that are currently being offered to assist during COVID-19. Speakers will give an overview of their funding programs and how to apply for them. After the presentations\, there will be a question and answer period.  \n  \nConfirmed Speakers:  \n\nGina Arsens\, Chief Financial Officer\, Canada’s Digital Technology Supercluster\nEric Atkinson\, Industrial Technology Advisor\, NRC IRAP\n\n  \nEvent Details  \nDate: June 25\, 2020 \nTime: 10:00 – 11:00 AM \nTickets: Free for everyone  \nThis Spotlight Speaking Series is proudly presented by \n \nOur McCarthy Spotlight Speaking Series is one of our longest-standing event series – and one in which our attendees see the most value. Held twice a year\, these events start with presentations on specific topics by local representatives of LifeSciences BC members. Typically\, the event is attended by a cross-section of approximately 40 of our life sciences community members representing mainly industry\, NPOs\, and Government. \nIn the past\, the series has featured topics focusing on attracting and keeping good talent\, technology and licensing\, M&A and Capital Markets\, to name a few. 
URL:https://scienceinvancouver.com/event/mccarthy-spotlight-speaking-series-non-dilutive-funding-programs-2/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200625T100000
DTEND;TZID=America/Vancouver:20200625T110000
DTSTAMP:20260405T050005
CREATED:20200608T203949Z
LAST-MODIFIED:20200608T203949Z
UID:27801-1593079200-1593082800@scienceinvancouver.com
SUMMARY:McCarthy Spotlight Speaking Series: Non-Dilutive Funding Programs
DESCRIPTION:LifeSciences BC is pleased to present our Summer McCarthy Spotlight Speaking Event for Thursday\, June 25\, 2020. This webinar will cover the various non-dilutive funding programs that are currently being offered to assist during COVID-19. Speakers will give an overview of their funding programs and how to apply for them. After the presentations\, there will be a question and answer period.  \n  \nConfirmed Speakers:  \n\nGina Arsens\, Chief Financial Officer\, Canada’s Digital Technology Supercluster\nEric Atkinson\, Industrial Technology Advisor\, NRC IRAP\n\n  \nEvent Details  \nDate: June 25\, 2020 \nTime: 10:00 – 11:00 AM \nTickets: Free for everyone  \nThis Spotlight Speaking Series is proudly presented by \n \nOur McCarthy Spotlight Speaking Series is one of our longest-standing event series – and one in which our attendees see the most value. Held twice a year\, these events start with presentations on specific topics by local representatives of LifeSciences BC members. Typically\, the event is attended by a cross-section of approximately 40 of our life sciences community members representing mainly industry\, NPOs\, and Government. \nIn the past\, the series has featured topics focusing on attracting and keeping good talent\, technology and licensing\, M&A and Capital Markets\, to name a few. 
URL:https://scienceinvancouver.com/event/mccarthy-spotlight-speaking-series-non-dilutive-funding-programs-3/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200625T100000
DTEND;TZID=America/Vancouver:20200625T110000
DTSTAMP:20260405T050005
CREATED:20200608T203949Z
LAST-MODIFIED:20200608T203949Z
UID:30884-1593079200-1593082800@scienceinvancouver.com
SUMMARY:McCarthy Spotlight Speaking Series: Non-Dilutive Funding Programs
DESCRIPTION:LifeSciences BC is pleased to present our Summer McCarthy Spotlight Speaking Event for Thursday\, June 25\, 2020. This webinar will cover the various non-dilutive funding programs that are currently being offered to assist during COVID-19. Speakers will give an overview of their funding programs and how to apply for them. After the presentations\, there will be a question and answer period.  \n  \nConfirmed Speakers:  \n\nGina Arsens\, Chief Financial Officer\, Canada’s Digital Technology Supercluster\nEric Atkinson\, Industrial Technology Advisor\, NRC IRAP\n\n  \nEvent Details  \nDate: June 25\, 2020 \nTime: 10:00 – 11:00 AM \nTickets: Free for everyone  \nThis Spotlight Speaking Series is proudly presented by \n \nOur McCarthy Spotlight Speaking Series is one of our longest-standing event series – and one in which our attendees see the most value. Held twice a year\, these events start with presentations on specific topics by local representatives of LifeSciences BC members. Typically\, the event is attended by a cross-section of approximately 40 of our life sciences community members representing mainly industry\, NPOs\, and Government. \nIn the past\, the series has featured topics focusing on attracting and keeping good talent\, technology and licensing\, M&A and Capital Markets\, to name a few. 
URL:https://scienceinvancouver.com/event/mccarthy-spotlight-speaking-series-non-dilutive-funding-programs-4/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200625T100000
DTEND;TZID=America/Vancouver:20200625T110000
DTSTAMP:20260405T050005
CREATED:20200608T203949Z
LAST-MODIFIED:20200608T203949Z
UID:32344-1593079200-1593082800@scienceinvancouver.com
SUMMARY:McCarthy Spotlight Speaking Series: Non-Dilutive Funding Programs
DESCRIPTION:LifeSciences BC is pleased to present our Summer McCarthy Spotlight Speaking Event for Thursday\, June 25\, 2020. This webinar will cover the various non-dilutive funding programs that are currently being offered to assist during COVID-19. Speakers will give an overview of their funding programs and how to apply for them. After the presentations\, there will be a question and answer period.  \n  \nConfirmed Speakers:  \n\nGina Arsens\, Chief Financial Officer\, Canada’s Digital Technology Supercluster\nEric Atkinson\, Industrial Technology Advisor\, NRC IRAP\n\n  \nEvent Details  \nDate: June 25\, 2020 \nTime: 10:00 – 11:00 AM \nTickets: Free for everyone  \nThis Spotlight Speaking Series is proudly presented by \n \nOur McCarthy Spotlight Speaking Series is one of our longest-standing event series – and one in which our attendees see the most value. Held twice a year\, these events start with presentations on specific topics by local representatives of LifeSciences BC members. Typically\, the event is attended by a cross-section of approximately 40 of our life sciences community members representing mainly industry\, NPOs\, and Government. \nIn the past\, the series has featured topics focusing on attracting and keeping good talent\, technology and licensing\, M&A and Capital Markets\, to name a few. 
URL:https://scienceinvancouver.com/event/mccarthy-spotlight-speaking-series-non-dilutive-funding-programs-5/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200629T080000
DTEND;TZID=America/Vancouver:20200629T100000
DTSTAMP:20260405T050005
CREATED:20200622T185251Z
LAST-MODIFIED:20200622T185251Z
UID:11786-1593417600-1593424800@scienceinvancouver.com
SUMMARY:Gairdner Global Perspectives Panel: COVID-19 - The Canadian Research Response
DESCRIPTION:There has been an unprecedented global scientific response to the COVID-19 pandemic. Many scientists have rapidly changed their research directions to help accelerate our understanding of the virus\, to search for new treatments\, to develop effective vaccines and to rapidly implement clinical trials. The societal and public health impacts of the pandemic need to be assessed and interventions tested. \nThe Gairdner Foundation seeks to highlight and celebrate the importance of rigorous science and global collaboration in solving major global health issues.  The Canadian government and other funders of research have recently invested considerable funding into major COVID-19 research initiatives in Canada that are contributing to the international efforts to alleviate the pandemic challenge.  This panel will explore some of these Canadian initiatives with the leaders involved. The panel will also discuss the importance of Open Science and international collaboration in promoting equitable access to public health interventions and therapies. \n  \nModerator: \nJanet Rossant – President & Scientific Director\, The Gairdner Foundation \n  \nWelcome and Overview \nMona Nemer – Chief Scientist of Canada \nMichael Strong – President\, CIHR-IRSC \nAudience Q&A \n  \nCanadian vaccine efforts \nLakshmi Krishnan – Director General\, Human Health Therapeutics\, National Research Council of Canada \nVolker Gerdts – Director & CEO\, VIDO-Intervac \nGary Kobinger – Canada Research Chair in Immunotherapy and Innovative Vaccine Platforms\, Université Laval \nAudience Q&A               \n  \nPopulation-wide research and impact \nRob Annan – President & CEO\, Genome Canada \nCatherine Hankins – Co-Chair\, COVID-19 Immunity Task Force\, McGill University \nCarrie Bourrassa\, Scientific Director\, CIHR Institute of Indigenous Peoples’ Health \nAudience Q&A \n  \nCoordination and collaboration \nGuy Rouleau – Director\, Montreal Neurological Institute and Hospital\, McGill University & 2020 Canada Gairdner Wightman Award Laureate \nVivek Goel – Vice-President\, Research and Innovation\, and Strategic Initiatives\, University of Toronto \nAudience Q&A
URL:https://scienceinvancouver.com/event/gairdner-global-perspectives-panel-covid-19-the-canadian-research-response/
LOCATION:Online
ATTACH;FMTTYPE=image/png:https://scienceinvancouver.com/wp-content/uploads/sites/1/2020/06/Gairdner-awards.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200629T080000
DTEND;TZID=America/Vancouver:20200629T100000
DTSTAMP:20260405T050005
CREATED:20200622T185251Z
LAST-MODIFIED:20200622T185251Z
UID:26197-1593417600-1593424800@scienceinvancouver.com
SUMMARY:Gairdner Global Perspectives Panel: COVID-19 - The Canadian Research Response
DESCRIPTION:There has been an unprecedented global scientific response to the COVID-19 pandemic. Many scientists have rapidly changed their research directions to help accelerate our understanding of the virus\, to search for new treatments\, to develop effective vaccines and to rapidly implement clinical trials. The societal and public health impacts of the pandemic need to be assessed and interventions tested. \nThe Gairdner Foundation seeks to highlight and celebrate the importance of rigorous science and global collaboration in solving major global health issues.  The Canadian government and other funders of research have recently invested considerable funding into major COVID-19 research initiatives in Canada that are contributing to the international efforts to alleviate the pandemic challenge.  This panel will explore some of these Canadian initiatives with the leaders involved. The panel will also discuss the importance of Open Science and international collaboration in promoting equitable access to public health interventions and therapies. \n  \nModerator: \nJanet Rossant – President & Scientific Director\, The Gairdner Foundation \n  \nWelcome and Overview \nMona Nemer – Chief Scientist of Canada \nMichael Strong – President\, CIHR-IRSC \nAudience Q&A \n  \nCanadian vaccine efforts \nLakshmi Krishnan – Director General\, Human Health Therapeutics\, National Research Council of Canada \nVolker Gerdts – Director & CEO\, VIDO-Intervac \nGary Kobinger – Canada Research Chair in Immunotherapy and Innovative Vaccine Platforms\, Université Laval \nAudience Q&A               \n  \nPopulation-wide research and impact \nRob Annan – President & CEO\, Genome Canada \nCatherine Hankins – Co-Chair\, COVID-19 Immunity Task Force\, McGill University \nCarrie Bourrassa\, Scientific Director\, CIHR Institute of Indigenous Peoples’ Health \nAudience Q&A \n  \nCoordination and collaboration \nGuy Rouleau – Director\, Montreal Neurological Institute and Hospital\, McGill University & 2020 Canada Gairdner Wightman Award Laureate \nVivek Goel – Vice-President\, Research and Innovation\, and Strategic Initiatives\, University of Toronto \nAudience Q&A
URL:https://scienceinvancouver.com/event/gairdner-global-perspectives-panel-covid-19-the-canadian-research-response-2/
LOCATION:Online
ATTACH;FMTTYPE=image/png:https://scienceinvancouver.com/wp-content/uploads/sites/1/2020/06/Gairdner-awards.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200629T080000
DTEND;TZID=America/Vancouver:20200629T100000
DTSTAMP:20260405T050005
CREATED:20200622T185251Z
LAST-MODIFIED:20200622T185251Z
UID:27812-1593417600-1593424800@scienceinvancouver.com
SUMMARY:Gairdner Global Perspectives Panel: COVID-19 - The Canadian Research Response
DESCRIPTION:There has been an unprecedented global scientific response to the COVID-19 pandemic. Many scientists have rapidly changed their research directions to help accelerate our understanding of the virus\, to search for new treatments\, to develop effective vaccines and to rapidly implement clinical trials. The societal and public health impacts of the pandemic need to be assessed and interventions tested. \nThe Gairdner Foundation seeks to highlight and celebrate the importance of rigorous science and global collaboration in solving major global health issues.  The Canadian government and other funders of research have recently invested considerable funding into major COVID-19 research initiatives in Canada that are contributing to the international efforts to alleviate the pandemic challenge.  This panel will explore some of these Canadian initiatives with the leaders involved. The panel will also discuss the importance of Open Science and international collaboration in promoting equitable access to public health interventions and therapies. \n  \nModerator: \nJanet Rossant – President & Scientific Director\, The Gairdner Foundation \n  \nWelcome and Overview \nMona Nemer – Chief Scientist of Canada \nMichael Strong – President\, CIHR-IRSC \nAudience Q&A \n  \nCanadian vaccine efforts \nLakshmi Krishnan – Director General\, Human Health Therapeutics\, National Research Council of Canada \nVolker Gerdts – Director & CEO\, VIDO-Intervac \nGary Kobinger – Canada Research Chair in Immunotherapy and Innovative Vaccine Platforms\, Université Laval \nAudience Q&A               \n  \nPopulation-wide research and impact \nRob Annan – President & CEO\, Genome Canada \nCatherine Hankins – Co-Chair\, COVID-19 Immunity Task Force\, McGill University \nCarrie Bourrassa\, Scientific Director\, CIHR Institute of Indigenous Peoples’ Health \nAudience Q&A \n  \nCoordination and collaboration \nGuy Rouleau – Director\, Montreal Neurological Institute and Hospital\, McGill University & 2020 Canada Gairdner Wightman Award Laureate \nVivek Goel – Vice-President\, Research and Innovation\, and Strategic Initiatives\, University of Toronto \nAudience Q&A
URL:https://scienceinvancouver.com/event/gairdner-global-perspectives-panel-covid-19-the-canadian-research-response-3/
LOCATION:Online
ATTACH;FMTTYPE=image/png:https://scienceinvancouver.com/wp-content/uploads/sites/1/2020/06/Gairdner-awards.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200629T080000
DTEND;TZID=America/Vancouver:20200629T100000
DTSTAMP:20260405T050005
CREATED:20200622T185251Z
LAST-MODIFIED:20200622T185251Z
UID:30895-1593417600-1593424800@scienceinvancouver.com
SUMMARY:Gairdner Global Perspectives Panel: COVID-19 - The Canadian Research Response
DESCRIPTION:There has been an unprecedented global scientific response to the COVID-19 pandemic. Many scientists have rapidly changed their research directions to help accelerate our understanding of the virus\, to search for new treatments\, to develop effective vaccines and to rapidly implement clinical trials. The societal and public health impacts of the pandemic need to be assessed and interventions tested. \nThe Gairdner Foundation seeks to highlight and celebrate the importance of rigorous science and global collaboration in solving major global health issues.  The Canadian government and other funders of research have recently invested considerable funding into major COVID-19 research initiatives in Canada that are contributing to the international efforts to alleviate the pandemic challenge.  This panel will explore some of these Canadian initiatives with the leaders involved. The panel will also discuss the importance of Open Science and international collaboration in promoting equitable access to public health interventions and therapies. \n  \nModerator: \nJanet Rossant – President & Scientific Director\, The Gairdner Foundation \n  \nWelcome and Overview \nMona Nemer – Chief Scientist of Canada \nMichael Strong – President\, CIHR-IRSC \nAudience Q&A \n  \nCanadian vaccine efforts \nLakshmi Krishnan – Director General\, Human Health Therapeutics\, National Research Council of Canada \nVolker Gerdts – Director & CEO\, VIDO-Intervac \nGary Kobinger – Canada Research Chair in Immunotherapy and Innovative Vaccine Platforms\, Université Laval \nAudience Q&A               \n  \nPopulation-wide research and impact \nRob Annan – President & CEO\, Genome Canada \nCatherine Hankins – Co-Chair\, COVID-19 Immunity Task Force\, McGill University \nCarrie Bourrassa\, Scientific Director\, CIHR Institute of Indigenous Peoples’ Health \nAudience Q&A \n  \nCoordination and collaboration \nGuy Rouleau – Director\, Montreal Neurological Institute and Hospital\, McGill University & 2020 Canada Gairdner Wightman Award Laureate \nVivek Goel – Vice-President\, Research and Innovation\, and Strategic Initiatives\, University of Toronto \nAudience Q&A
URL:https://scienceinvancouver.com/event/gairdner-global-perspectives-panel-covid-19-the-canadian-research-response-4/
LOCATION:Online
ATTACH;FMTTYPE=image/png:https://scienceinvancouver.com/wp-content/uploads/sites/1/2020/06/Gairdner-awards.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200629T080000
DTEND;TZID=America/Vancouver:20200629T100000
DTSTAMP:20260405T050005
CREATED:20200622T185251Z
LAST-MODIFIED:20200622T185251Z
UID:32355-1593417600-1593424800@scienceinvancouver.com
SUMMARY:Gairdner Global Perspectives Panel: COVID-19 - The Canadian Research Response
DESCRIPTION:There has been an unprecedented global scientific response to the COVID-19 pandemic. Many scientists have rapidly changed their research directions to help accelerate our understanding of the virus\, to search for new treatments\, to develop effective vaccines and to rapidly implement clinical trials. The societal and public health impacts of the pandemic need to be assessed and interventions tested. \nThe Gairdner Foundation seeks to highlight and celebrate the importance of rigorous science and global collaboration in solving major global health issues.  The Canadian government and other funders of research have recently invested considerable funding into major COVID-19 research initiatives in Canada that are contributing to the international efforts to alleviate the pandemic challenge.  This panel will explore some of these Canadian initiatives with the leaders involved. The panel will also discuss the importance of Open Science and international collaboration in promoting equitable access to public health interventions and therapies. \n  \nModerator: \nJanet Rossant – President & Scientific Director\, The Gairdner Foundation \n  \nWelcome and Overview \nMona Nemer – Chief Scientist of Canada \nMichael Strong – President\, CIHR-IRSC \nAudience Q&A \n  \nCanadian vaccine efforts \nLakshmi Krishnan – Director General\, Human Health Therapeutics\, National Research Council of Canada \nVolker Gerdts – Director & CEO\, VIDO-Intervac \nGary Kobinger – Canada Research Chair in Immunotherapy and Innovative Vaccine Platforms\, Université Laval \nAudience Q&A               \n  \nPopulation-wide research and impact \nRob Annan – President & CEO\, Genome Canada \nCatherine Hankins – Co-Chair\, COVID-19 Immunity Task Force\, McGill University \nCarrie Bourrassa\, Scientific Director\, CIHR Institute of Indigenous Peoples’ Health \nAudience Q&A \n  \nCoordination and collaboration \nGuy Rouleau – Director\, Montreal Neurological Institute and Hospital\, McGill University & 2020 Canada Gairdner Wightman Award Laureate \nVivek Goel – Vice-President\, Research and Innovation\, and Strategic Initiatives\, University of Toronto \nAudience Q&A
URL:https://scienceinvancouver.com/event/gairdner-global-perspectives-panel-covid-19-the-canadian-research-response-5/
LOCATION:Online
ATTACH;FMTTYPE=image/png:https://scienceinvancouver.com/wp-content/uploads/sites/1/2020/06/Gairdner-awards.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200629T113000
DTEND;TZID=America/Vancouver:20200629T143000
DTSTAMP:20260405T050005
CREATED:20200625T200219Z
LAST-MODIFIED:20200625T200219Z
UID:11823-1593430200-1593441000@scienceinvancouver.com
SUMMARY:2020 CIHR Project Grant Competitions: Ask Me Anything
DESCRIPTION:We know you have more questions about the 2020 Project Grant competitions. CIHR is offering three additional Ask Me Anything sessions to give you answers. \nWhen: \n\nMonday\, June 22: 2:30 p.m. – 4:00 p.m. ET\nLanguage: Presentation\, questions and answers in English and French\nThursday\, June 25: 2:30 p.m. – 4:00 p.m. ET\nLanguage: Presentation\, questions and answers in English and French\nMonday\, June 29: 2:30 p.m. – 4:00 p.m. ET\nLanguage: Presentation\, questions and answers in French\n\nLink to live events: \n\nMonday\, June 22: 2:30 p.m. – 4:00 p.m. ET\nJoin Microsoft Teams Meeting \nAsk questions in advance – code: pjt-ama-june22\nThursday\, June 25: 2:30 p.m. – 4:00 p.m. ET\nJoin Microsoft Teams Meeting \nAsk questions in advance – code: pjt-ama-june25\nMonday\, June 29: 2:30 p.m. – 4:00 p.m. ET (French)\nJoin Microsoft Teams Meeting \nAsk questions in advance – code: pjt-ama-29juin
URL:https://scienceinvancouver.com/event/2020-cihr-project-grant-competitions-ask-me-anything/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200629T113000
DTEND;TZID=America/Vancouver:20200629T143000
DTSTAMP:20260405T050005
CREATED:20200625T200219Z
LAST-MODIFIED:20200625T200219Z
UID:26201-1593430200-1593441000@scienceinvancouver.com
SUMMARY:2020 CIHR Project Grant Competitions: Ask Me Anything
DESCRIPTION:We know you have more questions about the 2020 Project Grant competitions. CIHR is offering three additional Ask Me Anything sessions to give you answers. \nWhen: \n\nMonday\, June 22: 2:30 p.m. – 4:00 p.m. ET\nLanguage: Presentation\, questions and answers in English and French\nThursday\, June 25: 2:30 p.m. – 4:00 p.m. ET\nLanguage: Presentation\, questions and answers in English and French\nMonday\, June 29: 2:30 p.m. – 4:00 p.m. ET\nLanguage: Presentation\, questions and answers in French\n\nLink to live events: \n\nMonday\, June 22: 2:30 p.m. – 4:00 p.m. ET\nJoin Microsoft Teams Meeting \nAsk questions in advance – code: pjt-ama-june22\nThursday\, June 25: 2:30 p.m. – 4:00 p.m. ET\nJoin Microsoft Teams Meeting \nAsk questions in advance – code: pjt-ama-june25\nMonday\, June 29: 2:30 p.m. – 4:00 p.m. ET (French)\nJoin Microsoft Teams Meeting \nAsk questions in advance – code: pjt-ama-29juin
URL:https://scienceinvancouver.com/event/2020-cihr-project-grant-competitions-ask-me-anything-2/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200629T113000
DTEND;TZID=America/Vancouver:20200629T143000
DTSTAMP:20260405T050005
CREATED:20200625T200219Z
LAST-MODIFIED:20200625T200219Z
UID:27816-1593430200-1593441000@scienceinvancouver.com
SUMMARY:2020 CIHR Project Grant Competitions: Ask Me Anything
DESCRIPTION:We know you have more questions about the 2020 Project Grant competitions. CIHR is offering three additional Ask Me Anything sessions to give you answers. \nWhen: \n\nMonday\, June 22: 2:30 p.m. – 4:00 p.m. ET\nLanguage: Presentation\, questions and answers in English and French\nThursday\, June 25: 2:30 p.m. – 4:00 p.m. ET\nLanguage: Presentation\, questions and answers in English and French\nMonday\, June 29: 2:30 p.m. – 4:00 p.m. ET\nLanguage: Presentation\, questions and answers in French\n\nLink to live events: \n\nMonday\, June 22: 2:30 p.m. – 4:00 p.m. ET\nJoin Microsoft Teams Meeting \nAsk questions in advance – code: pjt-ama-june22\nThursday\, June 25: 2:30 p.m. – 4:00 p.m. ET\nJoin Microsoft Teams Meeting \nAsk questions in advance – code: pjt-ama-june25\nMonday\, June 29: 2:30 p.m. – 4:00 p.m. ET (French)\nJoin Microsoft Teams Meeting \nAsk questions in advance – code: pjt-ama-29juin
URL:https://scienceinvancouver.com/event/2020-cihr-project-grant-competitions-ask-me-anything-3/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200629T113000
DTEND;TZID=America/Vancouver:20200629T143000
DTSTAMP:20260405T050005
CREATED:20200625T200219Z
LAST-MODIFIED:20200625T200219Z
UID:30899-1593430200-1593441000@scienceinvancouver.com
SUMMARY:2020 CIHR Project Grant Competitions: Ask Me Anything
DESCRIPTION:We know you have more questions about the 2020 Project Grant competitions. CIHR is offering three additional Ask Me Anything sessions to give you answers. \nWhen: \n\nMonday\, June 22: 2:30 p.m. – 4:00 p.m. ET\nLanguage: Presentation\, questions and answers in English and French\nThursday\, June 25: 2:30 p.m. – 4:00 p.m. ET\nLanguage: Presentation\, questions and answers in English and French\nMonday\, June 29: 2:30 p.m. – 4:00 p.m. ET\nLanguage: Presentation\, questions and answers in French\n\nLink to live events: \n\nMonday\, June 22: 2:30 p.m. – 4:00 p.m. ET\nJoin Microsoft Teams Meeting \nAsk questions in advance – code: pjt-ama-june22\nThursday\, June 25: 2:30 p.m. – 4:00 p.m. ET\nJoin Microsoft Teams Meeting \nAsk questions in advance – code: pjt-ama-june25\nMonday\, June 29: 2:30 p.m. – 4:00 p.m. ET (French)\nJoin Microsoft Teams Meeting \nAsk questions in advance – code: pjt-ama-29juin
URL:https://scienceinvancouver.com/event/2020-cihr-project-grant-competitions-ask-me-anything-4/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200629T113000
DTEND;TZID=America/Vancouver:20200629T143000
DTSTAMP:20260405T050005
CREATED:20200625T200219Z
LAST-MODIFIED:20200625T200219Z
UID:32359-1593430200-1593441000@scienceinvancouver.com
SUMMARY:2020 CIHR Project Grant Competitions: Ask Me Anything
DESCRIPTION:We know you have more questions about the 2020 Project Grant competitions. CIHR is offering three additional Ask Me Anything sessions to give you answers. \nWhen: \n\nMonday\, June 22: 2:30 p.m. – 4:00 p.m. ET\nLanguage: Presentation\, questions and answers in English and French\nThursday\, June 25: 2:30 p.m. – 4:00 p.m. ET\nLanguage: Presentation\, questions and answers in English and French\nMonday\, June 29: 2:30 p.m. – 4:00 p.m. ET\nLanguage: Presentation\, questions and answers in French\n\nLink to live events: \n\nMonday\, June 22: 2:30 p.m. – 4:00 p.m. ET\nJoin Microsoft Teams Meeting \nAsk questions in advance – code: pjt-ama-june22\nThursday\, June 25: 2:30 p.m. – 4:00 p.m. ET\nJoin Microsoft Teams Meeting \nAsk questions in advance – code: pjt-ama-june25\nMonday\, June 29: 2:30 p.m. – 4:00 p.m. ET (French)\nJoin Microsoft Teams Meeting \nAsk questions in advance – code: pjt-ama-29juin
URL:https://scienceinvancouver.com/event/2020-cihr-project-grant-competitions-ask-me-anything-5/
LOCATION:Online
END:VEVENT
END:VCALENDAR